Tower Research Capital LLC (TRC) - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 36 filers reported holding APTEVO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,453
+104.7%
13,495
+805.7%
0.00%
Q2 2023$2,1751,490
+1218.6%
0.00%
Q4 2022$0
-100.0%
113
-96.0%
0.00%
Q3 2022$9,000
-50.0%
2,808
+135.2%
0.00%
Q3 2021$18,000
+350.0%
1,194
+752.9%
0.00%
Q1 2021$4,000
-55.6%
140
-42.1%
0.00%
Q4 2020$9,000
-55.0%
242
-90.1%
0.00%
-100.0%
Q2 2020$20,000
+1900.0%
2,446
+761.3%
0.00%
Q1 2020$1,0002840.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$64,504,0009.85%
Stonepine Capital Management, LLC 18,280$670,0000.51%
Ghost Tree Capital, LLC 50,000$1,833,0000.41%
Anson Funds Management LP 45,462$1,666,0000.34%
RTW INVESTMENTS, LP 288,236$10,564,0000.18%
Dynamic Technology Lab Private Ltd 13,202$484,0000.08%
Alyeska Investment Group, L.P. 49,601$1,818,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 11,493$421,0000.02%
PURA VIDA INVESTMENTS, LLC 8,203$301,0000.01%
Renaissance Technologies 254,423$9,325,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders